Speaking during the meeting, Permanent Secretary – Technical Services, Kennedy Lishimpi described the study as a significant milestone in strengthening Zambia’s cholera response and advancing innovative vaccine delivery methods.
The research was conducted through a partnership between the Ministry of Health and the International Vaccine Institute, with support from Gavi, the Vaccine Alliance. It examined the use of Oral Cholera Vaccines under Controlled Temperature Chain conditions.
The CTC approach allows certain vaccines to be stored safely outside traditional cold chain temperatures for a limited and carefully monitored period. This method is particularly relevant for Zambia, where hard-to-reach communities, unreliable electricity supply, seasonal flooding and poor road networks can delay vaccine distribution.
Dr. Lishimpi said that although Government has invested significantly in strengthening cold chain systems, challenges remain, particularly in remote areas. He noted that the CTC model offers an opportunity to address last-mile delivery gaps, increase immunisation coverage and promote equitable access to vaccines without compromising safety or effectiveness.
The Ministry stated that findings from the study will inform national policy, guide operational procedures and support the integration of CTC-labelled Oral Cholera Vaccines into Zambia’s National Cholera Response Framework.
The Ministry reaffirmed its commitment to turning research evidence into practical action and strengthening partnerships that ensure scientific innovations benefit communities across the country.
